Microbix Biosystems Inc.

Through our technical and quality systems we provide the level of service and technical support that our customers require for adenovirus based research and production. Our adenovirus vectors, cells and services have been purchased by over 600 companies and researchers around the world. We have been providing adenovirus services for the past 8 years, forming lasting partnerships with many of the major biopharmaceutical and biotechnology researchers and companies.

Our success is measured by the satisfaction of our customers and in providing products and services that consistently meet and exceed their expectations.

Microbix Biosystems Inc. develops biological products and technologies. The Company was founded in 1988 as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies.

Welcome to Microbix, manufacturer of trusted solutions for the infectious disease industry for over 25 years.

Microbix has chosen to license the VIRUSMAX technology on a regional basis, starting with countries where vaccine supply is most deficient. Licenses are initially available to local domestic manufacturers, multinational manufacturers with facilities in the licensing region, and/or start up manufacturers’ facilities. The terms for such licenses are structured to include upfront and royalty payments.